We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SAGE market cap is 841.49M. The company's latest EPS is USD -9.0088 and P/E is -1.58.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.74M | 2.87M | 3.29M | 2.47M | 2.72M |
| Operating Income | -141.48M | -153.9M | -155.47M | -170.46M | -211.85M |
| Net Income | -137.32M | -147.15M | -146.83M | -160.33M | -201.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.87M | 1.11B | 6.31M | 7.69M | 86.46M |
| Operating Income | -708.12M | 596.23M | -460.91M | -546.99M | -579.85M |
| Net Income | -680.24M | 606.07M | -457.89M | -532.78M | -541.49M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.49B | 1.36B | 1.22B | 1.08B | 949.66M |
| Total Liabilities | 105.95M | 103.85M | 87.56M | 97.91M | 133M |
| Total Equity | 1.38B | 1.25B | 1.13B | 984.38M | 816.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.08B | 2.16B | 1.83B | 1.36B | 882.28M |
| Total Liabilities | 139.5M | 86.91M | 96.26M | 103.85M | 82.75M |
| Total Equity | 944.66M | 2.07B | 1.73B | 1.25B | 799.53M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -333.1M | -460.04M | -153.68M | -285.2M | -421.07M |
| Investing | 235.66M | 325.43M | 194.87M | 240.46M | 400.85M |
| Financing | 3.04M | 3.07M | 2.67M | 3.52M | 6.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -528.71M | 664.28M | -378.18M | -460.04M | -540.59M |
| Investing | -143.16M | 442.68M | -1B | 325.43M | 442.91M |
| Financing | 607.62M | 426.76M | 13.33M | 3.07M | 6.03M |
| Market Cap | 841.49M |
| Price to Earnings Ratio | -1.58 |
| Price to Sales Ratio | 9.87 |
| Price to Cash Ratio | 12.01 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 60.11M |
| Average Volume (1 week) | 1.42M |
| Average Volume (1 Month) | 1.26M |
| 52 Week Change | -71.34% |
| 52 Week High | 59.99 |
| 52 Week Low | 10.92 |
| Spread (Intraday) | 0.05 (0.36%) |
| Company Name | Sage Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.sagerx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
